Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Blum

Showing results (261-270 of 336) with videos related to

Pageof 34
Sort By:
International Journal of Environmental Research and Public Health|November 13, 2021
Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All AddictionsKenneth Blum, Abdalla Bowirrat, Eric R Braverman, et al.
Journal of Reward Deficiency Syndrome|June 9, 2015
NIDA-Drug Addiction Treatment Outcome Study (DATOS) Relapse as a Function of Spirituality/ReligiosityStephen J Schoenthaler, Kenneth Blum, Eric R Braverman, et al.
Journal of Personalized Medicine|April 3, 2021
A Novel Precision Approach to Overcome the "Addiction Pandemic" by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis RestorationKenneth Blum, Shan Kazmi, Edward J Modestino, et al.
Clinical and Experimental Psychology|August 10, 2023
Evidence for the <i>DRD2</i> Gene as a Determinant of Reward Deficiency Syndrome (RDS)Kenneth Blum, Abdala Bowirrat, Igor Elman, et al.
Current Psychopharmacology|May 21, 2020
In Search of Reward Deficiency Syndrome (RDS)-free Controls: The "Holy Grail" in Genetic Addiction Risk TestingKenneth Blum, David Baron, Lisa Lott, et al.
Heliyon|August 23, 2023
Personalized repetitive transcranial magnetic stimulation (prtms®) for post-traumatic stress disorder (ptsd) in military combat veteransMilan T Makale, Shaghayegh Abbasi, Chad Nybo, et al.
Acta Scientific Neurology|August 29, 2025
Is It Scientifically Possible To 'Cure" Reward Deficiency Syndrome (RDS) Via Transplice Molecular Genetic Technology?Kenneth Blum, Alireza Sharafshah, Kai -Uwe-Lewandowski, et al.
Substance Use & Misuse|December 20, 2017
A Systematic, Intensive Statistical Investigation of Data from the Comprehensive Analysis of Reported Drugs (CARD) for Compliance and Illicit Opioid Abstinence in Substance Addiction Treatment with Buprenorphine/naloxoneKenneth Blum, David Han, Edward J Modestino, et al.
Journal of Addiction Research & Therapy|November 26, 2013
Withdrawal from Buprenorphine/Naloxone and Maintenance with a Natural Dopaminergic Agonist: A Cautionary NoteKenneth Blum, Marlene Oscar-Berman, John Femino, et al.
Journal of Addiction Research & Therapy|November 26, 2013
Declinol, a Complex Containing Kudzu, Bitter Herbs (Gentian, Tangerine Peel) and Bupleurum, Significantly Reduced Alcohol Use Disorders Identification Test (AUDIT) Scores in Moderate to Heavy Drinkers: A Pilot StudySteven Kushner, David Han, Marlene Oscar-Berman, et al.
Pageof 34

Showing results (261-270 of 336) with videos related to

Sort By:
Pageof 34
International Journal of Environmental Research and Public Health|November 13, 2021
Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All AddictionsKenneth Blum, Abdalla Bowirrat, Eric R Braverman, et al.
Journal of Reward Deficiency Syndrome|June 9, 2015
NIDA-Drug Addiction Treatment Outcome Study (DATOS) Relapse as a Function of Spirituality/ReligiosityStephen J Schoenthaler, Kenneth Blum, Eric R Braverman, et al.
Journal of Personalized Medicine|April 3, 2021
A Novel Precision Approach to Overcome the "Addiction Pandemic" by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis RestorationKenneth Blum, Shan Kazmi, Edward J Modestino, et al.
Clinical and Experimental Psychology|August 10, 2023
Evidence for the <i>DRD2</i> Gene as a Determinant of Reward Deficiency Syndrome (RDS)Kenneth Blum, Abdala Bowirrat, Igor Elman, et al.
Current Psychopharmacology|May 21, 2020
In Search of Reward Deficiency Syndrome (RDS)-free Controls: The "Holy Grail" in Genetic Addiction Risk TestingKenneth Blum, David Baron, Lisa Lott, et al.
Heliyon|August 23, 2023
Personalized repetitive transcranial magnetic stimulation (prtms®) for post-traumatic stress disorder (ptsd) in military combat veteransMilan T Makale, Shaghayegh Abbasi, Chad Nybo, et al.
Acta Scientific Neurology|August 29, 2025
Is It Scientifically Possible To 'Cure" Reward Deficiency Syndrome (RDS) Via Transplice Molecular Genetic Technology?Kenneth Blum, Alireza Sharafshah, Kai -Uwe-Lewandowski, et al.
Substance Use & Misuse|December 20, 2017
A Systematic, Intensive Statistical Investigation of Data from the Comprehensive Analysis of Reported Drugs (CARD) for Compliance and Illicit Opioid Abstinence in Substance Addiction Treatment with Buprenorphine/naloxoneKenneth Blum, David Han, Edward J Modestino, et al.
Journal of Addiction Research & Therapy|November 26, 2013
Withdrawal from Buprenorphine/Naloxone and Maintenance with a Natural Dopaminergic Agonist: A Cautionary NoteKenneth Blum, Marlene Oscar-Berman, John Femino, et al.
Journal of Addiction Research & Therapy|November 26, 2013
Declinol, a Complex Containing Kudzu, Bitter Herbs (Gentian, Tangerine Peel) and Bupleurum, Significantly Reduced Alcohol Use Disorders Identification Test (AUDIT) Scores in Moderate to Heavy Drinkers: A Pilot StudySteven Kushner, David Han, Marlene Oscar-Berman, et al.
Pageof 34